Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 11;7(8):e1465164. doi: 10.1080/2162402X.2018.1465164

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Author(s). Published with license by Taylor & Francis Group, LLC

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

PMC Copyright notice

Figure 3. — Effect of aOX40+vax combined treatment on Treg number and phenotype. (A) Cytofluorometric plots of a representative mouse per group (at 17 weeks of age): vaccine alone (upper row), aOX40+vax (lower row). Panels from left to right show: Treg frequency over total splenocytes, CD103+ cells over Treg, GITR expression level (Mean fluorescence intensity, MFI) over Treg, CD103+ Treg frequency in gated CD4+ splenocytes. (B) Each bar represents the mean and SEM from mice of the different groups studied (at 17 weeks of age). For comparison, data from untreated mice and from mice treated with aOX40 alone are shown. Groups: untreated, n = 3; aOX40, n = 10; vaccine, n = 20; aOX40+vax, n = 25. Significance at the Student's t test is reported.